central and peripheral glp 1 systems independently suppress eating Comparing the anorexigenic effects mechanisms of gut-derived GLP-1 and its receptor agonists: insights into incretin-based therapies for obesity | Diabetology International Frontiers | GLP-1 Suppresses Feeding
Description
LARC, long-acting reversible contraception
Many patients use these drugs for weight management rather than diabetes, and these medications may not be captured in routine medication reconciliation if patients do not volunteer the information
Variations in the GLP1R gene, GIPR gene, and serotonin-pathway genes influence both therapeutic response and the likelihood of experiencing anxiety during treatment
Participants receiving efpeglenatide more frequently achieved weight loss of 5% or 10%
Heimbrger, S
